2guo: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:
|PDB= 2guo |SIZE=350|CAPTION= <scene name='initialview01'>2guo</scene>, resolution 1.90&Aring;
|PDB= 2guo |SIZE=350|CAPTION= <scene name='initialview01'>2guo</scene>, resolution 1.90&Aring;
|SITE=  
|SITE=  
|LIGAND= <scene name='pdbligand=NA:SODIUM+ION'>NA</scene> and <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>
|LIGAND= <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>
|ACTIVITY=  
|ACTIVITY=  
|GENE= HLA-A ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]), B2M ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
|GENE= HLA-A ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]), B2M ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
|DOMAIN=
|RELATEDENTRY=[[2gtw|2GTW]], [[2gtz|2GTZ]], [[2gt9|2GT9]], [[1jfi|1JFI]], [[1jht|1JHT]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2guo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2guo OCA], [http://www.ebi.ac.uk/pdbsum/2guo PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2guo RCSB]</span>
}}
}}


Line 16: Line 19:


==Disease==
==Disease==
Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Ankylosing spondylitis, susceptibility to, 1 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Hypoproteinemia, hypercatabolic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=109700 109700]], Stevens-Johnson syndrome, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]]
Known disease associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Ankylosing spondylitis, susceptibility to, 1 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Stevens-Johnson syndrome, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Hypoproteinemia, hypercatabolic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=109700 109700]]


==About this Structure==
==About this Structure==
Line 27: Line 30:
[[Category: Baker, B M.]]
[[Category: Baker, B M.]]
[[Category: Borbulevych, O Y.]]
[[Category: Borbulevych, O Y.]]
[[Category: GOL]]
[[Category: NA]]
[[Category: cancer vaccine]]
[[Category: cancer vaccine]]
[[Category: hla-a2]]
[[Category: hla-a2]]
Line 37: Line 38:
[[Category: x-ray crystallography]]
[[Category: x-ray crystallography]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 17:09:19 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 03:21:53 2008''